Wesleyan University

Dr. Holly Mehr Joins Fertility & Surgical Associates of California

Retrieved on: 
月曜日, 5月 6, 2024

Fertility & Surgical Associates of California (FSAC) is pleased to welcome Dr. Holly Mehr MD, MSEd, double board certified in Reproductive Endocrinology and Obstetrics and Gynecology, to our clinic.

Key Points: 
  • Fertility & Surgical Associates of California (FSAC) is pleased to welcome Dr. Holly Mehr MD, MSEd, double board certified in Reproductive Endocrinology and Obstetrics and Gynecology, to our clinic.
  • Dr. Mehr is now scheduling new patient appointments at our Santa Monica location.
  • Your goals are my goals, and we work together to find the best path forward,” said Dr. Mehr.
  • Dr. Mehr completed her undergraduate studies at Wesleyan University and her medical degree at the Icahn School of Medicine at Mount Sinai.

UBS Private Wealth Management hires Regina Bronson and Alex Gitomer in New York City

Retrieved on: 
金曜日, 4月 12, 2024

UBS Private Wealth Management today announced that Regina Bronson and Alex Gitomer will be joining the firm as Managing Directors and Private Wealth Advisors in New York City.

Key Points: 
  • UBS Private Wealth Management today announced that Regina Bronson and Alex Gitomer will be joining the firm as Managing Directors and Private Wealth Advisors in New York City.
  • “Regina and Alex are talented advisors that have decades of combined experience advising ultra-high-net-worth clients on the complexities of maintaining and growing wealth through generations,” said Tom Conigatti, Market Director at UBS Private Wealth Management.
  • Alex Gitomer provides customized investment advice and comprehensive wealth management solutions to ultra-high-net-worth families, not-for-profit organizations and certain institutional clients.
  • Previously, Hilary spent nine years with Goldman Sachs and was most recently a Vice President in Private Wealth Management.

NUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

Retrieved on: 
月曜日, 4月 22, 2024

They replace John Waters, who recently passed away, and Dr. Daniel Stites, who fulfilled his one-year term Board commitment.

Key Points: 
  • They replace John Waters, who recently passed away, and Dr. Daniel Stites, who fulfilled his one-year term Board commitment.
  • The Board has determined that Mr. Saunders satisfies the current independent director standards established by the rules of The Nasdaq Stock Market.
  • Dr. Spears is board certified in Emergency Medicine by the American Board of Emergency Medicine and is a Fellow of the American College of Emergency Physicians.
  • Nutex Health is a leader in this micro hospital sector and I'm glad to be a part of the Company," said Dr. Spears.

Moses Singer Welcomes Back Tech & Data Specialist Liberty McAteer

Retrieved on: 
月曜日, 4月 1, 2024

Moses & Singer LLP is pleased to announce the return of Liberty McAteer as a partner in its Intellectual Property and AI & Data Law groups as the firm continues its strategic investment in growing their Data and AI practice.

Key Points: 
  • Moses & Singer LLP is pleased to announce the return of Liberty McAteer as a partner in its Intellectual Property and AI & Data Law groups as the firm continues its strategic investment in growing their Data and AI practice.
  • Liberty rejoins the firm after serving as Deputy Counsel at FreeWire Technologies, Inc., a Silicon Valley based battery-integrated EV charging station manufacturer.
  • “Liberty’s deep software and programming background sets him apart from other transactional lawyers,” said Dean Swagert , Moses Singer Managing Partner and co-chair of the Corporate Practice Group.
  • Liberty is also an active coder and charter member of TechGC, a peer community for professional development.

Tercera Expands Investment Team with New Partner Garrett Blank

Retrieved on: 
火曜日, 4月 2, 2024

CHICAGO, April 2, 2024 /PRNewswire/ -- Tercera , a growth-focused investment firm specializing in IT professional services, today announced the addition of finance executive and technology investor Garrett Blank as partner.

Key Points: 
  • CHICAGO, April 2, 2024 /PRNewswire/ -- Tercera , a growth-focused investment firm specializing in IT professional services, today announced the addition of finance executive and technology investor Garrett Blank as partner.
  • At Tercera, he will lead the investment team and be responsible for sourcing, executing, and monitoring investments in third-wave businesses .
  • Prior to Abry Partner, Blank was an investment banking analyst at Deutsche Bank.
  • "Tercera is a firm where I have the opportunity to build market leaders, create jobs and improve the communities around us."

AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN PHASE 1 CLINICAL TRIAL, STRENGTHENS LEADERSHIP TEAM AND RAISES ADDITIONAL $50 MILLION FINANCING

Retrieved on: 
木曜日, 3月 28, 2024

BERKELEY, Calif., March 28, 2024 /PRNewswire/ -- Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel and highly selective therapeutics that potently inhibit the mTORC1 pathway, today announced that it has dosed the first cohort of participants in a Phase 1 clinical trial for its lead development candidate AV078, a first-in-class CNS penetrant selective mTORC1 inhibitor. Supporting this transition into the clinic, the company has also expanded its leadership team with the appointment of seasoned industry veterans William Greene, M.D., Chief Investment Officer at Hevolution, and Justin Gover, former Chief Executive Officer of GW Pharmaceuticals, to the company's Board of Directors, and appointed Micah Zajic as Chief Financial Officer. The company also recently completed a $50 million financing, led by Hevolution.

Key Points: 
  • Aeovian has assembled a compelling platform for the development of selective mTORC1 inhibitors," said Dr. Greene, CIO at Hevolution.
  • In the $50M financing, Hevolution was joined by existing investors Apollo Health Ventures, Sofinnova Investments, venBio, Evotec and b2venture.
  • This financing will support the completion of the Phase 1 clinical trial in healthy volunteers and prepare for the start of a subsequent Phase 2 clinical trial in adult and pediatric patients with TSC refractory epilepsy.
  • As CEO, he built and led Iconic Therapeutics through discovery, clinical development, and venture financing, which culminated in a successful sale of the company.

Post University Appoints Accomplished Executive and Academic Leader as Chief Academic Officer

Retrieved on: 
月曜日, 3月 11, 2024

WATERBURY, Conn., March 11, 2024 (GLOBE NEWSWIRE) -- Post University is pleased to announce the appointment of Sandra G. Affenito, Ph.D., as Chief Academic Officer.

Key Points: 
  • WATERBURY, Conn., March 11, 2024 (GLOBE NEWSWIRE) -- Post University is pleased to announce the appointment of Sandra G. Affenito, Ph.D., as Chief Academic Officer.
  • As Chief Academic Officer, Dr. Affenito will provide the executive leadership and vision to ensure enriched, personalized learning experiences for all students to realize their fullest potential.
  • “I am thrilled to welcome Sandra to the Post family and look forward to her insight and guidance as we plan for the future,” said Post University CEO and President John L. Hopkins.
  • She is a 2020 Executive Leadership Academy (ELA) Fellow of the University of California, Berkeley-Leading in a Multicultural and Global Environment.

High School Scholars from Underserved Communities Nationwide Recognized for High Achievement in College Courses Offered by Nation's Top Universities

Retrieved on: 
木曜日, 2月 15, 2024

NEW YORK, Feb. 15, 2024 /PRNewswire/ -- The National Educational Equity Lab (Ed Equity Lab), an education justice nonprofit that works to bridge the gap between high school and college for students from historically marginalized, low-income communities, today announced over 750 inductees selected for its 2023-24 Honor Society nationwide - from Albuquerque, Baton Rouge, and Flint to Los Angeles, New York, and Miami.

Key Points: 
  • "We're grateful for the passionate commitment of our high school and university partners, who are expanding opportunities for these scholars to advance and demonstrate their vast talent. "
  • Scholars in this year's Honor Society will be recognized in a ceremony tonight, February 15, featuring university professors, high school teachers, district leaders, family, and members of the National Education Equity Lab board.
  • "Scholars from 16 of our high schools are among the top performing scholars in the nation in these college courses — propelling their skills, confidence, and college and career opportunities.
  • The following schools participating in the Ed Equity Lab all have students inducted into this semester's Honor Society:
    Glenview College Prep High School, Principal Ecton
    Aspire Vanguard College Preparatory Academy, Principal Saldana
    Birmingham Community Charter High School, Principal Bennett
    Diego Rivera Learning Complex Green Design STEAM Academy, Principal Chavez
    Huntington Park Senior High School, Principal Garibaldi
    Marquez High School of Social Justice, Principal Guzman
    San Pedro Senior High School, Principal Aubele
    Thirty-Second Street USC Performing Arts, Principal Kehrley
    Valley Academy of Arts & Sciences, Principal Hanock
    Woodrow Wilson Senior High School, Principal Verbera
    Hialeah Miami Lakes Senior High School, Principal Ramirez
    Miami Central Senior High School, Principal Sands
    Miami Coral Park Senior High School, Principal Weiner
    Miami Norland Senior High School, Principal Gaines-Miller
    North Miami Beach Senior High School, Principal Milliken
    South Dade Senior High School, Principal De Armas
    South Miami Senior High School, Principal Penton
    Southwest Miami Senior High School, Principal Bulnes
    William H. Turner Technical Arts Senior High School, Principal Feazier
    The SEED School of Miami, Principal Thomas
    Thornton Fractional North High School, Principal Rucinski
    Thornton Fractional South High School, Principal Gourley
    George Washington Carver High School, Principal Byrant
    KIPP Academy Lynn Collegiate High School, Principal Clarke
    Duplin Early College High School, Principal Smith

CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board

Retrieved on: 
水曜日, 2月 7, 2024

BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company developing treatments for degenerative diseases of the brain, today announced the appointment of Joshua Boger, Ph.D., to its Board of Directors (Board) and as Chair of the Board. Dr. Boger is an innovative scientist and highly successful business executive who brings extensive drug development and biopharmaceutical company leadership experience to CervoMed as it progresses toward an important inflection point. Topline data from the RewinD-LB Phase 2b clinical trial evaluating neflamapimod in dementia with Lewy bodies (DLB) is expected in the second half of 2024. The Board Chair position was formerly held by CervoMed co-founder Dr. Sylvie Gregoire, who will continue to serve as a director.

Key Points: 
  • The Board Chair position was formerly held by CervoMed co-founder Dr. Sylvie Gregoire, who will continue to serve as a director.
  • “It is a pleasure to welcome Joshua, the founder of Vertex and an esteemed industry leader, to our Board of Directors,” said John Alam, M.D., Chief Executive Officer of CervoMed.
  • Dr. Joshua Boger is an industry veteran who has served in multiple scientific and business leadership roles in his 40+ year career.
  • He continued to serve on the Vertex Board and Chair Vertex’s Science & Technology Committee until 2017.

Frontier Airlines Announces Promotions Among Executive Leadership

Retrieved on: 
水曜日, 2月 7, 2024

DENVER, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Frontier Airlines, Inc., a subsidiary of Frontier Group Holdings, Inc. (NASDAQ: ULCC), today announced several promotions among its executive leadership team.

Key Points: 
  • DENVER, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Frontier Airlines, Inc., a subsidiary of Frontier Group Holdings, Inc. (NASDAQ: ULCC), today announced several promotions among its executive leadership team.
  • Diamond and Schuller’s promotions became effective February 1, 2024 and Moore’s promotion becomes effective March 15, 2024.
  • “Each of these individuals has been instrumental in the growth of our company,” said Barry Biffle, CEO, Frontier Airlines.
  • I wish to thank them for their continued support in helping to lead Frontier Airlines into the future.”